Effect of valproic acid on mitochondrial epigenetics
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Valproic acid (valproate), an anticonvulsant and a mood stabilizer, is a potent histone deacetylase inhibitor and a widely utilized pharmacological tool for neuroepigenetic research including DNA methylation. However, only nuclear but not mitochondrial DNA (mtDNA) has been investigated for the effects of valproate on the formation of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). Using mouse 3T3-L1 cells, we investigated the effects of short (1 day) and prolonged (3 days) valproate treatment on global mtDNA 5mC content, global and mtDNA sequence-specific 5hmC content, mRNA levels for ten-eleven-translocation (TET) enzymes involved in 5hmC formation, and the mitochondrial content of TET proteins. Only 5hmC but not 5mC content in mtDNA was affected (decreased) by valproate, and only after the prolonged treatment. This action of valproate was mimicked by MS-275, a class I histone deacetylase inhibitor. The prolonged but not the short valproate treatment decreased the expression of Tet1 mRNA and reduced the mitochondrial content of the TET1 protein. Hence, a likely scenario for a valproate-induced 5hmC decrease in mtDNA may involve nuclear histone deacetylase inhibition (mitochondria do not contain histones) causing the initial increase of Tet1 transcription, which is followed by a delayed compensatory decrease of Tet1 expression and a reduced presence of TET1 protein in mitochondria. Further research is needed to elucidate the functional implications of epigenetic modifications of mtDNA. The observed effects of valproate on mitochondrial epigenetics may have implications for a better understanding of both therapeutic and unwanted effects of this drug and possibly other histone deacetylase inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 2×
“Since the discovery that the anticonvulsant mood stabilizer valproic acid (VPA; valproate) is also a potent histone deacetylase (HDAC) inhibitor (Phiel et al., 2001), VPA became a widely utilized pharmacological tool for neuroepigenetic research (Detich et al.”
BackgroundCognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676 · cited 1×
“With respect to histone acetylation, the emphasis has been on HDAC inhibitors (Chuang et al., 2009; Fischer et al., 2010; Grayson et al., 2010; Haggarty and Tsai, 2011, Kazantsev et al., 2008; Sakharkar et al., 2012).”
MethodShock, L. S., Thakkar, P. V., Peterson, E. J., Moran, R. G., & Taylor, S. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012311108 · Cited by 555
Jin, S.-G., Kadam, S., & Pfeifer, G. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq223 · Cited by 437 · cited 1×
“Detecting and measuring sequence-specific 5hmC DNA modifications and distinguishing 5hmC from 5mC presents a technical challenge (Jin et al., 2010).”
BackgroundValproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345 · cited 1×
“…is also a potent histone deacetylase (HDAC) inhibitor (Phiel et al., 2001), VPA became a widely utilized pharmacological tool for neuroepigenetic research (Detich et al., 2003; Dong et al., 2010; Guidotti et al., 2009; Jeong et al., 2003; Kundakovic et al., 2009; Tremolizzo et © 2012 Elsevier B.V.”
BackgroundIs there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171 · cited 1×
“With respect to histone acetylation, the emphasis has been on HDAC inhibitors (Chuang et al., 2009; Fischer et al., 2010; Grayson et al., 2010; Haggarty and Tsai, 2011, Kazantsev et al., 2008; Sakharkar et al., 2012).”
MethodCharacterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling
Guidotti, A., Dong, E., Kundakovic, M., Satta, R., Grayson, D. R., & Costa, E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.010 · Cited by 130 · cited 2×
“…is also a potent histone deacetylase (HDAC) inhibitor (Phiel et al., 2001), VPA became a widely utilized pharmacological tool for neuroepigenetic research (Detich et al., 2003; Dong et al., 2010; Guidotti et al., 2009; Jeong et al., 2003; Kundakovic et al., 2009; Tremolizzo et © 2012 Elsevier B.V.”
BackgroundCurrent status and future prospects for epigenetic psychopharmacology
Boks, M. P., de Jong, N. M., Kas, M. J. H., Vinkers, C. H., Fernandes, C., Kahn, R. S., Mill, J., & Ophoff, R. A. (2012) · Epigenetics · doi:10.4161/epi.7.1.18688 · Cited by 89 · cited 1×
“The field of neuroepigenetics is becoming important for a better understanding of brain functioning (Riccio, 2010) and for the development of a putative epigenetic psychopharmacology (Boks et al., 2012; Marder et al., 2011).”
BackgroundAdvancing drug discovery for schizophrenia
Marder, S. R., Roth, B., Sullivan, P. F., Scolnick, E. M., Nestler, E. J., Geyer, M. A., Welnberger, D. R., Karayiorgou, M., Guidotti, A., Gingrich, J., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06216.x · Cited by 25 · cited 3×
“The field of neuroepigenetics is becoming important for a better understanding of brain functioning (Riccio, 2010) and for the development of a putative epigenetic psychopharmacology (Boks et al., 2012; Marder et al., 2011).”
BackgroundFlax, J. D., & Soloway, P. D. (2011) · Nature Neuroscience · doi:10.1038/nn.2988 · Cited by 7 · cited 1×
“More recently, the focus has shifted to the family of TET (ten-eleven-translocation) enzymes (TET1, TET2, and TET3), which are involved in the nuclear conversion of 5mC into 5hmC (Flax and Soloway, 2011; Iyer et al., 2009; Tahiliani et al., 2009).”
Background
Cited by
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Lu, Y., Chan, Y.-T., Tan, H.-Y., Li, S., Wang, N., & Feng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01197-3 · Cited by 499
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Mitochondrial DNA Methylation and Human Diseases
Stoccoro, A., & Coppedè, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094594 · Cited by 185
“Moreover, while the presence of DNMT1 in mitochondria has been further confirmed by other research groups [46,47], also the presence of the de novo DNMT3A and DNMT3B [48–50] and of the TET enzymes [51,52] has been identified in mitochondria.”
BackgroundCpG methylation patterns of human mitochondrial DNA
Liu, B., Du, Q., Chen, L., Fu, G., Li, S., Fu, L., Zhang, X., Ma, C., & Bin, C. (2016) · Scientific Reports · doi:10.1038/srep23421 · Cited by 179
Evidence Suggesting Absence of Mitochondrial DNA Methylation
Mechta, M., Ingerslev, L. R., Fabre, O., Picard, M., & Barrès, R. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00166 · Cited by 157
Metadata
- Authors
- Chen, H., Dzitoyeva, S., & Manev, H.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 690
- Issue
- 1-3
- Pages
- 51-59
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1992023919
- Cited by
- 81
- References
- 11
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.